| Financial Year |
March 31 2023 |
| Monetary Funds |
1,305,312,922.86 |
| Held-for-trading Financial Assets |
1,252,630,224.50 |
| Notes Receivable |
-- |
| Accounts Receivable |
719,101,238.36 |
| Advances to Suppliers |
104,721,373.30 |
| Other Receivables |
87,969,004.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,138,921.32 |
| Total Current Assets |
3,516,873,685.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
990,421,002.56 |
| Investment Properties |
-- |
| Fixed Assetes |
60,607,919.34 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
692,303,404.37 |
| R&D expenses |
-- |
| Goodwill |
3,894,257,740.35 |
| Long-Term Deferred and Prepaid Expenses |
3,189,744.85 |
| Deferred Income Tax Assets |
10,486,577.81 |
| Other Non-Current Assets |
285,874,776.61 |
| Sub-Total of Non-Current Assets |
13,807,809,131.39 |
| Total Assets |
17,324,682,816.60 |
| Short-Term Loans |
605,397,559.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,373,416,247.92 |
| Accounts Received In Advance |
90,429,644.18 |
| Employee Compensation Payable |
129,720,536.34 |
| Taxes Payable |
80,000,441.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,212,355.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,837,956.63 |
| Other Current Liabilities |
2,473,798.19 |
| Sub-Total of Current Liabilities |
2,540,785,356.96 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
172,312,361.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
239,113,314.14 |
| Total Liabilities |
2,779,898,671.10 |
| Paid-In Capital(Or Share Stock) |
1,188,218,704.00 |
| Capital Surplus |
1,495,115,412.72 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
10,689,750,178.39 |
| Minority Stockholder's Interest |
1,750,771,528.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,794,012,617.27 |
| Owner's Equity（Stockholder's Equity） |
14,544,784,145.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,324,682,816.60 |
